Clinical Trial Update: Local DHEA and Estradiol on Dyspareunia in Postmenopausal Women [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating local DHEA and estradiol for dyspareunia in postmenopausal women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Genitourinary Syndrome of Menopause
• Vulvovaginal Atrophy

Drugs mentioned

• DHEA (dehydroepiandrosterone)
• ESTRADIOL (Estradiol)

Snippet

Sponsor: Angelica Lindén Hirschberg | Conditions: Vulvovaginal Atrophy, Genitourinary Syndrome of Menopause | Phase 4 | Status: COMPLETED